Durazzo Timothy C, Rothlind Johannes C, Cardenas Valerie A, Studholme Colin, Weiner Michael W, Meyerhoff Dieter J
Center for Neuroimaging of Neurodegenerative Diseases, San Francisco Veterans Administration Medical Center, USA.
Alcohol. 2007 Nov;41(7):489-501. doi: 10.1016/j.alcohol.2007.07.007. Epub 2007 Oct 17.
Alcohol use disorders (AUD) and chronic cigarette smoking are common among individuals with human immunodeficiency virus infection (HIV). Concurrent AUD in HIV is related to greater abnormalities in brain morphology and neurocognition than either condition alone. However, the potential influence of chronic smoking on brain morphology and neurocognition in those concurrently afflicted with AUD and HIV has not been examined. The goal of this retrospective analysis was to determine if chronic smoking affected neurocognition and brain morphology in a subsample of HIV-positive non-treatment-seeking heavy drinking participants (HD+) from our earlier work. Regional volumetric and neurocognitive comparisons were made among age-equivalent smoking HD+(n=17), nonsmoking HD+ (n=27), and nonsmoking HIV-negative light drinking controls (n=27) obtained from our original larger sample. Comprehensive neuropsychological assessment evaluated multiple neurocognitive domains of functioning and for potential psychiatric comorbidities. Quantitative volumetric measures of neocortical gray matter (GM), white matter (WM), subcortical structures, and sulcal and ventricular cerebral spinal fluid (CSF) were derived from high-resolution magnetic resonance images. The main findings were (1) smoking HD+ performed significantly worse than nonsmoking HD+ on measures of auditory-verbal (AV) learning, AV memory, and cognitive efficiency; (2) relative to controls, smoking HD+ demonstrated significantly lower neocortical GM volumes in all lobes except the occipital lobe, while nonsmoking HD+ showed only lower frontal GM volume compared with controls; (3) in the HD+ group, regional brain volumes and neurocognition were not influenced by viremia, highly active antiretroviral treatment, or Center for Disease Control symptom status, and no interactions were apparent with these variables or smoking status. Overall, the findings suggested that the direct and/or indirect effects of chronic cigarette smoking created an additional burden on the integrity of brain neurobiology and neurocognition in this cohort of HIV-positive heavy drinkers.
酒精使用障碍(AUD)和长期吸烟在感染人类免疫缺陷病毒(HIV)的个体中很常见。HIV感染者并发AUD与单独存在这两种情况相比,大脑形态和神经认知方面的异常更为严重。然而,长期吸烟对同时患有AUD和HIV的患者大脑形态和神经认知的潜在影响尚未得到研究。这项回顾性分析的目的是确定长期吸烟是否会影响我们早期研究中未寻求治疗的HIV阳性重度饮酒参与者(HD+)子样本的神经认知和大脑形态。对从我们最初的较大样本中选取的年龄相当的吸烟HD+组(n = 17)、不吸烟HD+组(n = 27)和不吸烟的HIV阴性轻度饮酒对照组(n = 27)进行了区域体积和神经认知比较。综合神经心理学评估评估了多个神经认知功能领域以及潜在的精神共病情况。新皮质灰质(GM)、白质(WM)、皮质下结构以及脑沟和脑室脑脊液(CSF)的定量体积测量来自高分辨率磁共振图像。主要发现如下:(1)在听觉语言(AV)学习、AV记忆和认知效率测量方面,吸烟HD+组的表现明显比不吸烟HD+组差;(2)相对于对照组,吸烟HD+组除枕叶外所有脑叶的新皮质GM体积均显著降低,而不吸烟HD+组与对照组相比仅额叶GM体积较低;(3)在HD+组中,区域脑体积和神经认知不受病毒血症、高效抗逆转录病毒治疗或疾病控制中心症状状态的影响,并且这些变量与吸烟状态之间没有明显的相互作用。总体而言,研究结果表明,长期吸烟的直接和/或间接影响给这组HIV阳性重度饮酒者的脑神经生物学和神经认知完整性带来了额外负担。